Pick Sun Pharma, Tech Mahindra: Dipan Mehta

Dipan Mehta, member of BSE and NSE told CNBC-TV18, "With usual disclosures that we have investments and recommendations within the midcap IT the companies which we like the best and which have come out with very decent set of numbers for September quarter are companies like Zensar Technologies, Tata Elxsi, CMC, Mindtree and Infotech Enterprises. All these companies have outperformed their peer group and Tech Mahindra which is somewhat a midcap, not a large cap as yet, but transitioning to a large cap also remains our favourite pick within the sector."

"In pharmaceuticals a lot of companies across the board did exceptionally well, but the investors are better off just sticking with large cap companies. Sun Pharmaceutical Industries which is absolutely the best performer despite its size and base effect, I would say that within that sector it remains the top pick and then down the line the other number two, number three players are Dr Reddys Laboratories and Lupin hold lot of promise," he said. "Broadly these are the two sectors within the export-oriented segment which investors could focus on. So long as the rupee remains at around these levels and we see mild improvement in global economy, these sectors will continue to benefit and show a very decent numbers going forward." "Lastly a lot of the rupee depreciation has still to flow through the company's performances and what we saw in the September quarter is just about the beginning. The next 2-3 quarters will show even more improvements coming through the top-line and bottom-line because of the rupee depreciation."